Home › Companies › Ginkgo Bioworks Holdings, Inc. › 2025-2026
Download data (CSV): ballot items · votes by manager · column guide.
Compiled from SEC Form N-PX filings and Ginkgo Bioworks Holdings, Inc.’s Form 8-K, filed June 12, 2026 (Item 5.07 on EDGAR). Page generated November 20, 2026.
Meeting of June 11, 2026: 8 items on Ginkgo Bioworks Holdings, Inc.’s Form 8-K, filed June 12, 2026: 6 elected · 2 approved.
Notable dissent: 1 director (12.9% against).
Dissent tiers, on the company’s own Form 8-K tally (support = FOR ÷ (FOR + AGAINST), or FOR ÷ (FOR + WITHHELD) on a withhold ballot; abstentions and broker non-votes excluded): shareholder proposals with 15% support or more are notable, 25% significant, 40% high; director nominees with 10% or more against or withheld are notable, 20% significant; say-on-pay under 80% support is notable, under 70% significant; equity and compensation plans with 15% or more against are notable, 25% significant; any other item the board put forward with 15% or more against is notable. How this is decided
Proxy season: 2023-2024 2024-2025 2025-2026
Activist investors: Anchorage Capital (13F, 2.8%, as of September 30, 2026)
Explore Ginkgo Bioworks Holdings, Inc. in the interactive database Compare manager voting policies
These tallies are Ginkgo Bioworks Holdings, Inc.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed June 12, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.
| Ballot item | For | Against | Abstain | Withheld | Broker non-votes | Support (of votes cast) | Reported outcome | Voting standard |
|---|---|---|---|---|---|---|---|---|
| Elect Director: Jason Kelly | 84,007,040 | 48,210 | 0 | -- | -- | 99.9% | Elected | — |
| Elect Director: Reshma Shetty | 84,007,040 | 48,210 | 0 | -- | -- | 99.9% | Elected | — |
| Elect Director: Ross Fubini | 100,125,571 | 7,977,143 | 3,696,487 | -- | 11,792,897 | 93% | Elected | — |
| Elect Director: Christian Henry | 94,211,345 | 13,927,076 | 3,660,780 | -- | 11,792,897 | 87% | Elected | — |
| Elect Director: Sri Kosuri | 99,675,907 | 8,421,356 | 3,701,938 | -- | 11,792,897 | 92% | Elected | — |
| Elect Director: Harry E. Sloan | 97,315,317 | 10,788,312 | 3,695,572 | -- | 11,792,897 | 90% | Elected | — |
| 2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm Proposal two was the ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered | 119,527,721 | 267,727 | 3,796,650 | -- | 0 | 99.8% | Approved | — |
| 3. Advisory vote to approve executive compensation Proposal three was an advisory vote to approve the compensation of the Company's named executive officers, designated to be voted upon by the holders of Class A common stock and Class B common stock, voting to | 95,058,585 | 12,502,153 | 4,238,463 | -- | 11,792,897 | 88% | Approved | — |
Source: Ginkgo Bioworks Holdings, Inc., Form 8-K, filed with the SEC on June 12, 2026 — read the filing on EDGAR.
See voting trends for Health Care companies, 2025-2026: shareholder support by sector and by company size.
208 asset managers disclosed a vote on at least one Ginkgo Bioworks Holdings, Inc. item in their SEC Form N-PX filings. Each item below shows how many of them voted on it, and how. Share totals are the shares those managers' funds voted, summed across every fund they report.
Combines 4 wordings of this item as funds reported it.
87% Majority: yes · of votes cast
Prior year: 92.3% for (June 12, 2025 meeting) ▼ 5.2 pts
Description as filed by funds: Election of Directors: Christian Henry
Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“Elect Director: Christian Henry”): 94,211,345 for, 13,927,076 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The results of the vote were as follows: Director nominees designated to be elected by holders of Class B common stock: Director nominees designated to be elected by holders of Class A and Class B common stock (voting together as a single class): Pursuant to the foregoing votes, the six nominees l…”
Support: 87% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 815,064 for, 4,979,358 against, 9 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 2,768 | 1,991,068 | 9 | 0 | Against |
| BlackRock | 0 | 1,213,171 | 0 | 0 | Against |
| Fidelity | 618,007 | 16,667 | 0 | 0 | For |
| PIMCO | 0 | 489,372 | 0 | 0 | Against |
| Charles Schwab | 0 | 332,833 | 0 | 0 | Against |
| EXCHANGE TRADED CONCEPTS TRUST | 0 | 321,721 | 0 | 0 | Against |
| State Street | 196 | 171,431 | 0 | 0 | Against |
| American Century | 0 | 87,386 | 0 | 0 | Against |
| Northern Lights Fund Trust IV | 83,268 | 0 | 0 | 0 | For |
| MFS | 0 | 40,639 | 0 | 0 | Against |
| Columbia Threadneedle | 40,383 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 0 | 37,656 | 0 | 0 | Against |
| Equitable | 0 | 31,363 | 0 | 0 | Against |
| Nationwide | 0 | 28,969 | 0 | 0 | Against |
| Lincoln Financial | 0 | 28,400 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 22,017 | 0 | 0 | Against |
| Jackson National | 19,810 | 0 | 0 | 0 | For |
| Global X | 0 | 19,679 | 0 | 0 | Against |
| Bridge Builder Trust | 0 | 18,688 | 0 | 0 | Against |
| Northern Trust | 16,445 | 0 | 0 | 0 | For |
| TIAA | 16,049 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 15,919 | 0 | 0 | Against |
| Pacific Life | 0 | 15,766 | 0 | 0 | Against |
| Brighthouse | 0 | 11,484 | 0 | 0 | Against |
| John Hancock | 0 | 11,342 | 0 | 0 | Against |
Showing the 25 largest of 49 asset managers. All 49 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
90% Majority: yes · of votes cast
Prior year: 89.7% for (June 12, 2025 meeting) ▲ 0.3 pts
Description as filed by funds: Election of Directors: Harry E. Sloan
Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“Elect Director: Harry E. Sloan”): 97,315,317 for, 10,788,312 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The results of the vote were as follows: Director nominees designated to be elected by holders of Class B common stock: Director nominees designated to be elected by holders of Class A and Class B common stock (voting together as a single class): Pursuant to the foregoing votes, the six nominees l…”
Support: 90% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 3,426,086 for, 2,368,335 against, 9 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,989,086 | 4,750 | 9 | 0 | For |
| BlackRock | 1,213,171 | 0 | 0 | 0 | For |
| Fidelity | 16,667 | 618,007 | 0 | 0 | Against |
| PIMCO | 0 | 489,372 | 0 | 0 | Against |
| Charles Schwab | 0 | 332,833 | 0 | 0 | Against |
| EXCHANGE TRADED CONCEPTS TRUST | 0 | 321,721 | 0 | 0 | Against |
| State Street | 196 | 171,431 | 0 | 0 | Against |
| American Century | 0 | 87,386 | 0 | 0 | Against |
| Northern Lights Fund Trust IV | 83,268 | 0 | 0 | 0 | For |
| MFS | 0 | 40,639 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 40,383 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 37,656 | 0 | 0 | 0 | For |
| Equitable | 20,833 | 10,530 | 0 | 0 | Mixed |
| Nationwide | 2,173 | 26,796 | 0 | 0 | Mixed |
| Lincoln Financial | 0 | 28,400 | 0 | 0 | Against |
| AIG/SunAmerica | 0 | 22,017 | 0 | 0 | Against |
| Jackson National | 0 | 19,810 | 0 | 0 | Against |
| Global X | 0 | 19,679 | 0 | 0 | Against |
| Bridge Builder Trust | 18,688 | 0 | 0 | 0 | For |
| Northern Trust | 0 | 16,445 | 0 | 0 | Against |
| TIAA | 0 | 16,049 | 0 | 0 | Against |
| T. Rowe Price | 15,919 | 0 | 0 | 0 | For |
| Pacific Life | 15,766 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 11,484 | 0 | 0 | Against |
| John Hancock | 0 | 11,342 | 0 | 0 | Against |
Showing the 25 largest of 49 asset managers. All 49 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
93% Majority: yes · of votes cast
Prior year: 97.6% for (June 12, 2025 meeting) ▼ 5.0 pts
Description as filed by funds: Election of Directors: Ross Fubini
Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“Elect Director: Ross Fubini”): 100,125,571 for, 7,977,143 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The results of the vote were as follows: Director nominees designated to be elected by holders of Class B common stock: Director nominees designated to be elected by holders of Class A and Class B common stock (voting together as a single class): Pursuant to the foregoing votes, the six nominees l…”
Support: 93% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 4,107,225 for, 1,687,196 against, 9 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,993,812 | 24 | 9 | 0 | For |
| BlackRock | 1,213,171 | 0 | 0 | 0 | For |
| Fidelity | 16,667 | 618,007 | 0 | 0 | Against |
| PIMCO | 0 | 489,372 | 0 | 0 | Against |
| Charles Schwab | 332,833 | 0 | 0 | 0 | For |
| EXCHANGE TRADED CONCEPTS TRUST | 0 | 321,721 | 0 | 0 | Against |
| State Street | 171,465 | 162 | 0 | 0 | For |
| American Century | 0 | 87,386 | 0 | 0 | Against |
| Northern Lights Fund Trust IV | 83,268 | 0 | 0 | 0 | For |
| MFS | 40,639 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 40,383 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,656 | 0 | 0 | 0 | For |
| Equitable | 20,833 | 10,530 | 0 | 0 | Mixed |
| Nationwide | 2,173 | 26,796 | 0 | 0 | Mixed |
| Lincoln Financial | 28,400 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 22,017 | 0 | 0 | Against |
| Jackson National | 19,810 | 0 | 0 | 0 | For |
| Global X | 19,679 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 18,688 | 0 | 0 | 0 | For |
| Northern Trust | 16,445 | 0 | 0 | 0 | For |
| TIAA | 0 | 16,049 | 0 | 0 | Against |
| T. Rowe Price | 0 | 15,919 | 0 | 0 | Against |
| Pacific Life | 15,766 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 11,484 | 0 | 0 | Against |
| John Hancock | 0 | 11,342 | 0 | 0 | Against |
Showing the 25 largest of 49 asset managers. All 49 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
92% Majority: yes · of votes cast
Prior year: 97.5% for (June 12, 2025 meeting) ▼ 5.2 pts
Description as filed by funds: Election of Directors: Sri Kosuri
Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“Elect Director: Sri Kosuri”): 99,675,907 for, 8,421,356 against, per its Form 8-K filed June 12, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.
Reported outcome: Elected, in the filing’s own words: “The results of the vote were as follows: Director nominees designated to be elected by holders of Class B common stock: Director nominees designated to be elected by holders of Class A and Class B common stock (voting together as a single class): Pursuant to the foregoing votes, the six nominees l…”
Support: 92% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 4,655,048 for, 1,139,374 against, 9 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,992,270 | 1,567 | 9 | 0 | For |
| BlackRock | 1,213,171 | 0 | 0 | 0 | For |
| Fidelity | 634,674 | 0 | 0 | 0 | For |
| PIMCO | 0 | 489,372 | 0 | 0 | Against |
| Charles Schwab | 332,833 | 0 | 0 | 0 | For |
| EXCHANGE TRADED CONCEPTS TRUST | 0 | 321,721 | 0 | 0 | Against |
| State Street | 171,465 | 162 | 0 | 0 | For |
| American Century | 0 | 87,386 | 0 | 0 | Against |
| Northern Lights Fund Trust IV | 83,268 | 0 | 0 | 0 | For |
| MFS | 0 | 40,639 | 0 | 0 | Against |
| Columbia Threadneedle | 40,383 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,656 | 0 | 0 | 0 | For |
| Equitable | 20,833 | 10,530 | 0 | 0 | Mixed |
| Nationwide | 2,173 | 26,796 | 0 | 0 | Mixed |
| Lincoln Financial | 28,400 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 22,017 | 0 | 0 | Against |
| Jackson National | 0 | 19,810 | 0 | 0 | Against |
| Global X | 0 | 19,679 | 0 | 0 | Against |
| Bridge Builder Trust | 18,688 | 0 | 0 | 0 | For |
| Northern Trust | 16,445 | 0 | 0 | 0 | For |
| TIAA | 16,049 | 0 | 0 | 0 | For |
| T. Rowe Price | 15,919 | 0 | 0 | 0 | For |
| Pacific Life | 15,766 | 0 | 0 | 0 | For |
| Brighthouse | 0 | 11,484 | 0 | 0 | Against |
| John Hancock | 0 | 11,342 | 0 | 0 | Against |
Showing the 25 largest of 49 asset managers. All 49 are in the interactive database (link above).
Combines 4 wordings of this item as funds reported it.
88% Approved · of votes cast
Prior year: 99.2% for (June 12, 2025 meeting) ▼ 10.8 pts
Description as filed by funds: Advisory vote to approve executive compensation.
Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“3. Advisory vote to approve executive compensation Proposal three was an advisory vote to approve the compensation of the Company's named executive officers, designated to be voted upon by the holders of Class A common s”): 95,058,585 for, 12,502,153 against — passed, per its Form 8-K filed June 12, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Pursuant to the foregoing vote, the compensation of the Company's named executive officers was approved on an advisory basis.”
Support: 88% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 606,349 | 1,387,485 | 11 | 0 | Mixed |
| BlackRock | 0 | 1,213,171 | 0 | 0 | Against |
| Fidelity | 0 | 634,674 | 0 | 0 | Against |
| PIMCO | 0 | 489,372 | 0 | 0 | Against |
| Charles Schwab | 0 | 332,833 | 0 | 0 | Against |
| EXCHANGE TRADED CONCEPTS TRUST | 0 | 321,721 | 0 | 0 | Against |
| State Street | 171,465 | 162 | 0 | 0 | For |
| American Century | 0 | 87,386 | 0 | 0 | Against |
| Northern Lights Fund Trust IV | 83,268 | 0 | 0 | 0 | For |
| MFS | 0 | 40,639 | 0 | 0 | Against |
| Columbia Threadneedle | 0 | 40,383 | 0 | 0 | Against |
| QUANTITATIVE MASTER SERIES LLC | 0 | 37,656 | 0 | 0 | Against |
| Equitable | 0 | 31,363 | 0 | 0 | Against |
| Nationwide | 1,346 | 27,623 | 0 | 0 | Against |
| Lincoln Financial | 28,400 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 0 | 22,017 | 0 | 0 | Against |
| Jackson National | 0 | 19,810 | 0 | 0 | Against |
| Global X | 19,679 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 0 | 18,688 | 0 | 0 | Against |
| Northern Trust | 0 | 16,445 | 0 | 0 | Against |
| TIAA | 16,049 | 0 | 0 | 0 | For |
| T. Rowe Price | 0 | 15,919 | 0 | 0 | Against |
| Pacific Life | 0 | 15,766 | 0 | 0 | Against |
| Brighthouse | 0 | 11,484 | 0 | 0 | Against |
| John Hancock | 0 | 11,342 | 0 | 0 | Against |
Fund voting reports, all 49 managers: 951,134 for, 4,843,287 against, 11 abstained. Showing the 25 largest; every one is in the interactive database (link above).
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| VIKING GLOBAL INVESTORS LP | 0 | 0 | 3,577,128 | 0 | Abstain |
| BAILLIE GIFFORD & CO LTD | 2,141,649 | 0 | 0 | 0 | For |
| Capital Group | 1,746,363 | 0 | 0 | 0 | For |
| Legal & General Investment Management Ltd | 0 | 1,187,141 | 0 | 0 | Against |
| FORBES J M & CO LLP | 1,028,391 | 0 | 0 | 0 | For |
| GEODE CAPITAL MANAGEMENT, LLC | 0 | 772,649 | 0 | 0 | Against |
| BlackRock | 107,728 | 653,347 | 0 | 0 | Mixed |
| State Street | 692,356 | 9,541 | 0 | 0 | For |
| SB INVESTMENT ADVISERS (UK) LTD | 610,729 | 0 | 0 | 0 | For |
| PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 0 | 0 | 541,845 | 0 | Abstain |
| Charles Schwab | 0 | 332,844 | 0 | 0 | Against |
| Vanguard | 17,681 | 297,245 | 0 | 0 | Mixed |
| Northern Trust | 0 | 271,013 | 0 | 0 | Against |
| PACIFIC INVESTMENT MANAGEMENT CO LLC | 0 | 215,444 | 0 | 0 | Against |
| Universal-Investment-Gesellschaft mbH | 140,000 | 0 | 0 | 0 | For |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 0 | 116,102 | 0 | 0 | Against |
| T. Rowe Price | 0 | 109,699 | 0 | 0 | Against |
| a16z Capital Management, L.L.C. | 108,112 | 0 | 0 | 0 | For |
| Ensign Peak Advisors, Inc | 104,828 | 0 | 0 | 0 | For |
| American Century | 0 | 87,386 | 0 | 0 | Against |
| MELLON INVESTMENTS Corp | 0 | 86,693 | 0 | 0 | Against |
| REGENTS OF THE UNIVERSITY OF CALIFORNIA | 0 | 69,160 | 0 | 0 | Against |
| UBS | 0 | 60,891 | 0 | 0 | Against |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 0 | 57,079 | 0 | 0 | Against |
| Two Sigma | 0 | 45,624 | 0 | 0 | Against |
Institutional-manager reports, all 175 managers: 6,956,394 for, 4,714,377 against, 4,118,973 abstained, 204 not voted. Showing the 25 largest; every one is in the interactive database (link above).
Combines 2 wordings of this item as funds reported it.
99.8% Approved · of votes cast
Prior year: 99.8% for (June 12, 2025 meeting) unchanged
Description as filed by funds: Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026.
Ginkgo Bioworks Holdings, Inc.’s own tally for this item (“2. Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm Proposal two was the ratification of the appointment of Deloitte & Touche LLP as the Company's in”): 119,527,721 for, 267,727 against — passed, per its Form 8-K filed June 12, 2026 (Item 5.07).
Reported outcome: Approved, in the filing’s own words: “Pursuant to the foregoing vote, the ratification of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 was approved.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.
The 49 asset managers below reported 5,790,821 for, 3,601 against, 9 abstained.
| Asset manager | For | Against | Abstain | Withheld | Vote |
|---|---|---|---|---|---|
| Vanguard | 1,990,660 | 3,177 | 9 | 0 | For |
| BlackRock | 1,213,171 | 0 | 0 | 0 | For |
| Fidelity | 634,674 | 0 | 0 | 0 | For |
| PIMCO | 489,372 | 0 | 0 | 0 | For |
| Charles Schwab | 332,833 | 0 | 0 | 0 | For |
| EXCHANGE TRADED CONCEPTS TRUST | 321,721 | 0 | 0 | 0 | For |
| State Street | 171,454 | 173 | 0 | 0 | For |
| American Century | 87,386 | 0 | 0 | 0 | For |
| Northern Lights Fund Trust IV | 83,268 | 0 | 0 | 0 | For |
| MFS | 40,639 | 0 | 0 | 0 | For |
| Columbia Threadneedle | 40,383 | 0 | 0 | 0 | For |
| QUANTITATIVE MASTER SERIES LLC | 37,656 | 0 | 0 | 0 | For |
| Equitable | 31,363 | 0 | 0 | 0 | For |
| Nationwide | 28,969 | 0 | 0 | 0 | For |
| Lincoln Financial | 28,400 | 0 | 0 | 0 | For |
| AIG/SunAmerica | 22,017 | 0 | 0 | 0 | For |
| Jackson National | 19,810 | 0 | 0 | 0 | For |
| Global X | 19,679 | 0 | 0 | 0 | For |
| Bridge Builder Trust | 18,688 | 0 | 0 | 0 | For |
| Northern Trust | 16,445 | 0 | 0 | 0 | For |
| TIAA | 16,049 | 0 | 0 | 0 | For |
| T. Rowe Price | 15,919 | 0 | 0 | 0 | For |
| Pacific Life | 15,766 | 0 | 0 | 0 | For |
| Brighthouse | 11,484 | 0 | 0 | 0 | For |
| John Hancock | 11,342 | 0 | 0 | 0 | For |
Showing the 25 largest of 49 asset managers. All 49 are in the interactive database (link above).
Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 61,660,788 shares outstanding at the time of that meeting.
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | Vanguard | 3.23% |
| 2 | BlackRock | 1.97% |
| 3 | Fidelity | 1.03% |
| 4 | PIMCO | 0.79% |
| 5 | Charles Schwab | 0.54% |
| 6 | EXCHANGE TRADED CONCEPTS TRUST | 0.52% |
| 7 | State Street | 0.28% |
| 8 | American Century | 0.14% |
| 9 | Northern Lights Fund Trust IV | 0.14% |
| 10 | MFS | 0.07% |
| # | Asset manager | % of shares outstanding |
|---|---|---|
| 1 | VIKING GLOBAL INVESTORS LP | 5.80% |
| 2 | BAILLIE GIFFORD & CO LTD | 3.47% |
| 3 | Capital Group | 2.83% |
| 4 | Legal & General Investment Management Ltd | 1.93% |
| 5 | FORBES J M & CO LLP | 1.67% |
| 6 | GEODE CAPITAL MANAGEMENT, LLC | 1.25% |
| 7 | BlackRock | 1.23% |
| 8 | State Street | 1.14% |
| 9 | SB INVESTMENT ADVISERS (UK) LTD | 0.99% |
| 10 | PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C. | 0.88% |
As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row gives its source and the date its figure is as of: for Form 13F the quarter end it reports, for Schedules 13D and 13G the filing date, and for the proxy statement the date of its ownership table (or, where that date has not been read, the date the proxy was filed). The rows are therefore not all as of the same day.
| Holder | Shares | % outstanding | Source, as of |
|---|---|---|---|
| BlackRock | 3,642,347 | 5.91% | Form 13F, quarter ended March 31, 2026 |
| Cascade Investment, L.L.C. | 3,621,636 | 5.87% | Proxy statement (DEF 14A), table as of April 14, 2026 |
| VIKING GLOBAL INVESTORS LP | 3,577,128 | 5.80% | Schedule 13G, filed May 15, 2026 |
| Vanguard Group | 2,900,952 | 4.70% | Form 13F, quarter ended March 31, 2026 |
| BAILLIE GIFFORD & CO | 2,391,649 | 3.88% | Schedule 13G, filed February 5, 2026 |
| State Street | 1,346,659 | 2.18% | Form 13F, quarter ended March 31, 2026 |
| Geode Capital | 1,009,362 | 1.64% | Form 13F, quarter ended March 31, 2026 |
| Goldman Sachs | 929,862 | 1.51% | Form 13F, quarter ended March 31, 2026 |
| Bartholomew Canton | 774,990 | 1.26% | Proxy statement (DEF 14A), table as of April 14, 2026 |
| Reshma Shetty | 774,990 | 1.26% | Proxy statement (DEF 14A), table as of April 14, 2026 |
Percentages above are of 61,660,788 shares outstanding, as reported by Ginkgo Bioworks Holdings, Inc. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.
At Ginkgo Bioworks Holdings, Inc.'s shareholder meeting held June 11, 2026, in the 2025-2026 proxy season, 208 asset managers reported votes on at least one of its 6 ballot items in their SEC Form N-PX filings, covering 1,066 separate fund positions. On the most widely held item on that ballot — Advisory vote to approve executive compensation. — Ginkgo Bioworks Holdings, Inc.'s filing reports the proposal as approved, with 88% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Ginkgo Bioworks Holdings, Inc.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on June 12, 2026.
Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Ginkgo Bioworks Holdings, Inc.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on November 20, 2026; a live search always shows the current data.
Ginkgo Bioworks Holdings, Inc. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).
Proxy Votes Now, “Ginkgo Bioworks Holdings (DNA) 2026 Annual Meeting: Vote Results”, https://proxyvotesnow.com/company/ginkgo-bioworks-holdings-inc/2026 (version of November 20, 2026). Derived from SEC Form N-PX and Form 8-K filings; tables licensed CC BY 4.0. Licence: CC BY 4.0.